U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
about
Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1CODEHOP-mediated PCR - a powerful technique for the identification and characterization of viral genomes.Epstein-barr virus sequence variation-biology and diseaseA Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen MicropolymorphismEpstein-Barr Virus: Diseases Linked to Infection and TransformationAn examination of the steric effects of 5-tert-butylproline on the conformation of polyproline and the cooperative nature of type II to type I helical interconversionThe Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsMolecular evolution of the gamma-Herpesvirinae.Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesTarget DNA detection and quantitation on a single cell with single base resolution.Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude miceRestricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaDifferences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsAntibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.The expression and function of Epstein-Barr virus encoded latent genesMutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytesEpstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformationThe human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenancecdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis.The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoterEpstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsThe role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjectsNucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation siteThe EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.Multiple roles of Epstein-Barr virus SM protein in lytic replication.
P2860
Q24681418-ADDC36F8-1DF2-428C-86F9-FF15EEAEEC22Q24796759-C24B44B8-88BC-49DC-9726-82CA98A69BCCQ27003183-DDECFC62-5B5C-4CEE-B8A8-10B79D6C88E0Q27683527-CAFB0809-CAFF-46BA-8365-F7929AD5E1B4Q28074586-82F670F2-9ABD-4A6B-BD1D-B4E0A93F88CAQ28370646-5CA0ACFA-87BD-4E65-8DDF-DA4D791BB964Q30278553-9E637D4A-D8A3-4434-AB77-624CE2F06264Q30452144-79D4765F-4B48-4156-993D-B28C3AA5527AQ33552058-107DEFF1-CFCE-4BCD-8B00-01C5345C374FQ33640115-390AB44D-AD69-4E0B-9721-6ACCD4B382FDQ33647633-9DD3B9F9-CDB9-423C-8D3D-1F07C05CEE95Q33772225-539F9458-8128-4C5D-BB9F-82E848F18724Q33782872-3B48DB3D-6BA3-430E-A9EA-3265A479DDF1Q33795078-37351136-8F38-4593-9756-214A4DE4446FQ33816120-4ECB22D6-E261-42BA-B98A-0D14D7B66B94Q33841899-7198C6C2-50EE-4A98-8DA4-24CF8697BCA6Q33880494-7DE0BB4F-EC83-4629-AD10-9FB439FF43CAQ33880983-A27C54B8-0F1C-4066-98B9-11F35F9D8D01Q33891606-058F3AEF-36A9-45BA-953D-158E522AFCC8Q33929593-C32C18D0-8700-409C-BD1A-C4EB9A948C51Q33931549-78BCC407-0A76-4409-8C2C-B2425A113D44Q33998709-E7848533-3F01-46F4-B885-080CFA2423F1Q34089485-0F2075D5-279E-4D3B-902D-70FF200F55A1Q34299744-9407A180-B3FE-4E8F-A5D8-EB08DCF14712Q34324039-08EFC9C9-BBAF-41B4-9DB4-BA5A2FE0A783Q34327455-5FA14A4F-3E70-4771-B926-63BA942ADB3BQ34341875-99638BA9-3BEA-43B7-9F46-C1E5E033E6F4Q34353358-24679999-0DF2-451F-8E23-C6FACA1F0FD5Q34355226-23A49AFE-8EBC-4432-8C23-47B35E0AD4E1Q34366291-D64323D0-0BF8-4C12-AB71-9C249FBBA1CEQ34798881-68776B3D-E616-4F2C-83A7-5869D522950DQ35115666-509D94CE-C313-4FC9-9EEF-FA7E4F01746FQ35207078-6D35A981-FB3C-401E-9145-6902F3F0C175Q35463816-F810A5EA-9C60-46E8-816E-DF5A2B022CD5Q35586187-053B163F-9709-4845-8F3F-0094283F2392Q35586544-ABBCD51F-66EA-417A-960E-8A9BBE3729E4Q35616566-7D8FFCE7-D1BA-43E0-B932-C98A1FDBA4AFQ35664999-B7CFE376-9270-4CF5-AADD-BA701A61A08FQ35665981-A771EB0C-40AA-432D-BD78-0A5AEC41BB7EQ35785286-F5ECB263-B5CF-4585-9ECC-FDF2D12B0059
P2860
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@en
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@nl
type
label
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@en
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@nl
prefLabel
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@en
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@nl
P2093
P2860
P356
P1476
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
@en
P2093
K Hennessy
L Chamnankit
T Dambaugh
P2860
P304
P356
10.1073/PNAS.81.23.7632
P407
P577
1984-12-01T00:00:00Z